Submit Your Article CMED MEACR meeting
Home Print this page Email this page Users Online: 66
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2021  |  Volume : 10  |  Issue : 1  |  Page : 15-21

The association between androgen receptor expression and some pathological characteristics in patients with breast cancer

1 Molecular Pathology Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
2 Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
3 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Correspondence Address:
Seyed Hamid Madani
Molecular Pathology Research Center, Emam Reza Hospital, Zakaria Razi Bol, Kermanshah University of Medicl Science, Kermanshah
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ccij.ccij_103_20

Rights and Permissions

Context: Breast cancer is the most current malignancy in women all around the world. Considering the presence of the androgen receptor as a possible prognostic marker, attention has been given to its association with other molecular markers such as estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (Her 2)/neu, and clinicopathological characteristics and the target of cancer therapy. Aims: This study aimed to assess the level of androgen receptor (AR) and its association with other clinicopathological factors in patients with breast cancer. Settings and Design: Samples from 100 breast cancer patients were studied to evaluate the expression of AR using immunohistochemistry. Subjects and Methods: The association of AR was evaluated with ER, PR, and Her2 levels; age; tumor size; tumor grade; histological grade; nuclear grade; vascular invasion; perineural invasion; and lymph node involvement. The correlation between the expression of AR and other factors was assessed using t, Mann–Whitney, and Chi-square tests using SPSS. Results: Among 100 patients, 50 (50%) cases were AR positive. There was a significant correlation between AR expression and triple-negative breast cancer and the expressions of ER, PR, and Her2. However, there was no significant association between AR expression and other clinicopathological markers such as age, tumor size, type of tumor, and histological grade. Conclusion: Owning to the expanded expression of AR in 50% of patients with breast cancer in this study as well as the significant association between AR expression and triple-negative breast carcinoma, AR ER, PR, and Her 2, could be considered as a promising prognostic factor.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal